Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. (Q45962385)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. |
scientific article |
Statements
1 reference
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. (English)
1 reference
Mark Lebwohl
1 reference
Craig Leonardi
1 reference
Jörg C Prinz
1 reference
Philippe O Szapary
1 reference
Newman Yeilding
1 reference
Cynthia Guzzo
1 reference
Shu Li
1 reference
Ming-Chun Hsu
1 reference
Bruce Strober
1 reference
17 September 2011
1 reference
66
1 reference
5
1 reference
731-741
1 reference